BID (NM_001196) Human Mass Spec Standard
Specifications
| Product Data | |
| Tag | C-Myc/DDK |
|---|---|
| Species | Human |
| Expression Host | HEK293 |
| Expression cDNA Clone or AA Sequence | RC207261 |
| Predicted MW | 26.8 kDa |
| Protein Sequence | |
| Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
| Concentration | >0.05 µg/µL as determined by microplate BCA method |
| Labeling Method | Labeled with U- 13C6, 15N4-L-Arginine and U- 13C6, 15N2-L-Lysine |
| Buffer | 25 mM Tris-HCl, 100 mM glycine, pH 7.3 |
| Storage | Store at -80°C. Avoid repeated freeze-thaw cycles. |
| Stability | Stable for 3 months from receipt of products under proper storage and handling conditions. |
| Shipping | Dry Ice |
| Reference Data | |
| RefSeq | NP_001187 |
| RefSeq Size | 2217 |
| RefSeq ORF | 723 |
| Synonyms | FP497 |
| Locus ID | 637 |
| UniProt ID | P55957 |
| Cytogenetics | 22q11.21 |
| Summary | This gene encodes a death agonist that heterodimerizes with either agonist BAX or antagonist BCL2, and thus regulate apoptosis. The encoded protein is a member of the BCL-2 family of cell death regulators. It is a mediator of mitochondrial damage induced by caspase-8 (CASP8); CASP8 cleaves this encoded protein, and the COOH-terminal part translocates to mitochondria where it triggers cytochrome c release. Multiple alternatively spliced transcript variants have been found. provided by RefSeq, Aug 2020 |
| Protein Families | Druggable Genome |
| Protein Pathways | Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Apoptosis, Natural killer cell mediated cytotoxicity, p53 signaling pathway, Pathways in cancer, Viral myocarditis |
Reviews
Documents
| FAQs |
| SDS |
Resources
| Recombinant Protein Resources |
Other "BID" proteins (7)
| SKU | Description | Size | Price | |
|---|---|---|---|---|
| LC405092 | Lyophilized BID HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LC420074 | Lyophilized BID HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LY405092 | Transient overexpression lysate of BH3 interacting domain death agonist (BID), transcript variant 3 (as WB positive control) | 100 ug |
$436.00
|
|
| LY420074 | Transient overexpression lysate of BH3 interacting domain death agonist (BID), transcript variant 2 (as WB positive control) | 100 ug |
$436.00
|
|
| TP307261 | Recombinant protein of human BH3 interacting domain death agonist (BID), transcript variant 2, 20 µg | 20 ug |
$867.00
|
|
| TP720087 | Recombinant protein of human BH3 interacting domain death agonist (BID), transcript variant 2 | 10 ug |
$235.00
|
|
| TP760319 | Recombinant protein of human BH3 interacting domain death agonist (BID), transcript variant 1, full length, with N-terminal HIS tag, expressed in E.Coli, 50ug | 50 ug |
$270.00
|
|
Citations
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.